血液ガスおよび電解質分析装置市場レポート：製品タイプ、モダリティ、エンドユーザー、地域別、2025年～2033年

世界の血液ガスおよび電解質分析装置の市場規模は2024年に22億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに37億米ドルに達し、2025年から2033年にかけて5.37%の成長率（CAGR）を示すと予測しています。心血管合併症、がん、糖尿病など様々な慢性疾患の増加、装置の小型化と精度向上のための先端技術の統合の増加、ポイントオブケア（POC）検査サービスの採用の増加は、市場の成長を促す要因の一部です。

血液ガスおよび電解質分析装置とは、全血検体中の血液ガス（二酸化炭素と酸素の分圧）、pH、電解質、代謝物など、さまざまなパラメータを測定するために使用される医療機器を指します。代謝異常の検出や腎機能、心機能の測定に広く利用されています。また、血液中の異常な電解質レベル、酸素や二酸化炭素の交換レベル、患者の酸塩基平衡の判定にも役立ちます。さらに、糖尿病、血管内出血、薬物摂取などの特定にも役立ちます。近年、血液ガスおよび電解質分析装置は、その使いやすさ、費用対効果、正確性、迅速な結果から、臨床診断ラボやクリティカルケア病棟で絶大な人気を博しています。

血液ガスおよび電解質分析装置市場動向：

血液ガスおよび電解質分析装置は、作業プロセスを合理化し、エラーを最小限に抑え、最小限のメンテナンスで、正確な結果を迅速に提供することができます。その結果、集中治療室（ICU）、手術室、救急部における患者数の増加が市場成長の主な要因となっています。これに加えて、糖尿病や心血管障害などの慢性疾患の蔓延や、これらの病気を発症しやすい老年人口の増加が、製品需要を増大させています。さらに、高スループット、統合化、自動化システムに対する需要も大幅に増加しています。これとともに、血液ガスおよび電解質分析装置と検査情報システムおよび電子カルテとの統合が進み、ワークフローが合理化され、患者の健康状態を効果的にモニタリングできるようになったことが、市場成長の起爆剤となっています。さらに、いくつかの大手企業は、使いやすく取り扱いが簡単でメンテナンスの必要性が最小限のポータブル血液ガスおよび電解質分析装置の開発に多額の投資を行っています。その他の要因としては、ポイントオブケア検査（POCT）への嗜好の変化、ヘルスケア産業の発展、技術の進歩、製品の革新、広範な研究開発（R&D）活動などがあり、これらも良好な市場見通しを生み出しています。

本レポートで扱う主な質問

• 血液ガスおよび電解質分析装置市場の規模は？
• 2025年から2033年にかけての世界の血液ガスおよび電解質分析装置市場の予想成長率は？
• 血液ガスおよび電解質分析装置の世界市場を牽引する主要因は？
• 血液ガスおよび電解質分析装置の世界市場におけるCOVID-19の影響は？
• 血液ガスおよび電解質分析装置の世界市場における製品タイプ別の区分は？
• 血液ガスおよび電解質分析装置の世界市場におけるモダリティ別の区分は？
• 血液ガスおよび電解質分析装置の世界市場をエンドユーザー別に区分すると？
• 血液ガスおよび電解質分析装置の世界市場における主要地域は？
• 血液ガスおよび電解質分析装置の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の血液ガスおよび電解質分析装置市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品タイプ別

• 分析装置
• 消耗品

第7章 市場内訳：モダリティ別

• ベンチトップ
• ポータブル

第8章 市場内訳：エンドユーザー別

• 病院
• クリニック
• 外来手術センター
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories Inc.
  • Dalko Diagnostics
  • Erba Group（Transasia Bio-Medicals Ltd.）
  • Medica Corporation
  • Nova Biomedical Corporation
  • OPTI Medical Systems Inc.（IDEXX Laboratories）
  • Radiometer Medical ApS（Danaher Corporation）
  • Roche Holding AG
  • Siemens AG
  • WerfenLife S.A.

List of Figures

• Figure 1: Global: Blood Gas and Electrolyte Analyzer Market: Major Drivers and Challenges
• Figure 2: Global: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Blood Gas and Electrolyte Analyzer Market: Breakup by Product Type (in %), 2024
• Figure 5: Global: Blood Gas and Electrolyte Analyzer Market: Breakup by Modality (in %), 2024
• Figure 6: Global: Blood Gas and Electrolyte Analyzer Market: Breakup by End User (in %), 2024
• Figure 7: Global: Blood Gas and Electrolyte Analyzer Market: Breakup by Region (in %), 2024
• Figure 8: Global: Blood Gas and Electrolyte Analyzer (Analyzers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Blood Gas and Electrolyte Analyzer (Analyzers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Blood Gas and Electrolyte Analyzer (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Blood Gas and Electrolyte Analyzer (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Blood Gas and Electrolyte Analyzer (Benchtop) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Blood Gas and Electrolyte Analyzer (Benchtop) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Blood Gas and Electrolyte Analyzer (Portable) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Blood Gas and Electrolyte Analyzer (Portable) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Blood Gas and Electrolyte Analyzer (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Blood Gas and Electrolyte Analyzer (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Blood Gas and Electrolyte Analyzer (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Blood Gas and Electrolyte Analyzer (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Blood Gas and Electrolyte Analyzer (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Blood Gas and Electrolyte Analyzer (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Blood Gas and Electrolyte Analyzer (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Blood Gas and Electrolyte Analyzer (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: North America: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: North America: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: United States: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: United States: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Canada: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Canada: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: Asia-Pacific: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: Asia-Pacific: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: China: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: China: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Japan: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Japan: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: India: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: India: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: South Korea: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: South Korea: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: Australia: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: Australia: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: Indonesia: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: Indonesia: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: Others: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Others: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Europe: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Europe: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Germany: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Germany: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: France: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: France: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: United Kingdom: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: United Kingdom: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Italy: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Italy: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Spain: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Spain: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Russia: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: Russia: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Others: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Others: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Latin America: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Latin America: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Brazil: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Brazil: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Mexico: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: Mexico: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Others: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Others: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Middle East and Africa: Blood Gas and Electrolyte Analyzer Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Middle East and Africa: Blood Gas and Electrolyte Analyzer Market: Breakup by Country (in %), 2024
• Figure 72: Middle East and Africa: Blood Gas and Electrolyte Analyzer Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Global: Blood Gas and Electrolyte Analyzer Industry: SWOT Analysis
• Figure 74: Global: Blood Gas and Electrolyte Analyzer Industry: Value Chain Analysis
• Figure 75: Global: Blood Gas and Electrolyte Analyzer Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Blood Gas and Electrolyte Analyzer Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Blood Gas and Electrolyte Analyzer Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
• Table 3: Global: Blood Gas and Electrolyte Analyzer Market Forecast: Breakup by Modality (in Million USD), 2025-2033
• Table 4: Global: Blood Gas and Electrolyte Analyzer Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 5: Global: Blood Gas and Electrolyte Analyzer Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Blood Gas and Electrolyte Analyzer Market: Competitive Structure
• Table 7: Global: Blood Gas and Electrolyte Analyzer Market: Key Players

The global blood gas and electrolyte analyzer market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.37% during 2025-2033. The growing occurrence of various chronic illnesses like cardiovascular complications, cancer, and diabetes, increasing integration of advanced technologies to decrease the size of devices and enhance accuracy, and rising adoption of point-of-care (POC) testing services are some of the factors impelling the growth of the market.

Blood gas and electrolyte analyzers refer to medical devices used to measure various parameters, including blood gas (partial pressure of carbon dioxide and oxygen), pH, electrolytes, and metabolites, in a whole blood sample. They are widely utilized for the detection of metabolic imbalances and the measurement of renal and cardiac functions. They also help determine abnormal electrolyte levels in the blood, levels of oxygen or carbon dioxide exchange, and the acid-base balance of the patient. Moreover, they assist in identifying diabetes, blood vessel hemorrhage, and drug consumption. In recent years, blood gas and electrolyte analyzers have gained immense popularity across clinical diagnostic labs and critical care units due to their ease of use, cost-effectiveness, accuracy, and fast results.

Blood Gas and Electrolyte Analyzer Market Trends:

Blood gas and electrolyte analyzers can streamline work processes, minimize errors, require minimum maintenance, and provide accurate results quickly. As a result, the increasing number of patients in intensive care units (ICUs), operating rooms, and emergency departments represent the primary factor driving the market growth. Besides this, the widespread prevalence of chronic diseases, such as diabetes and cardiovascular disorders, and the growing geriatric population that is more susceptible to developing these medical ailments are augmenting the product demand. Additionally, there has been a significant increase in the demand for high throughput, integrated, and automated systems. Along with this, the rising integration of blood gas and electrolyte analyzers with laboratory information systems and electronic medical records to streamline the workflow and enable effective monitoring of patient health is catalyzing the market growth. Furthermore, several leading players are making heavy investments for the development of portable blood gas and electrolyte analyzers with easy-to-use and handle features and minimum maintenance requirements. Other factors, including the shifting preferences toward point-of-care testing (POCT), developments in the healthcare industry, technological advancements, product innovations, and extensive research and development (R&D) activities, are also creating a favorable market outlook.

Key Market Segmentation:

Breakup by Product Type:

• Analyzers
• Consumables

Breakup by Modality:

• Benchtop
• Portable

Breakup by End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories Inc., Dalko Diagnostics, Erba Group (Transasia Bio-Medicals Ltd.), Medica Corporation, Nova Biomedical Corporation, OPTI Medical Systems Inc. (IDEXX Laboratories), Radiometer Medical ApS (Danaher Corporation), Roche Holding AG, Siemens AG, and WerfenLife S.A.

Key Questions Answered in This Report

• 1.How big is the blood gas and electrolyte analyzer market?
• 2.What is the expected growth rate of the global blood gas and electrolyte analyzer market during 2025-2033?
• 3.What are the key factors driving the global blood gas and electrolyte analyzer market?
• 4.What has been the impact of COVID-19 on the global blood gas and electrolyte analyzer market?
• 5.What is the breakup of the global blood gas and electrolyte analyzer market based on the product type?
• 6.What is the breakup of the global blood gas and electrolyte analyzer market based on the modality?
• 7.What is the breakup of the global blood gas and electrolyte analyzer market based on the end user?
• 8.What are the key regions in the global blood gas and electrolyte analyzer market?
• 9.Who are the key players/companies in the global blood gas and electrolyte analyzer market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Blood Gas and Electrolyte Analyzer Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Analyzers
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Modality

• 7.1 Benchtop
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Portable
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Dalko Diagnostics
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Erba Group (Transasia Bio-Medicals Ltd.)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Medica Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Nova Biomedical Corporation
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 OPTI Medical Systems Inc. (IDEXX Laboratories)
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Radiometer Medical ApS (Danaher Corporation)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Roche Holding AG
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Siemens AG
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 WerfenLife S.A.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio